Global Hormonal Contraceptive Market by Method (Combined Oral Contraceptives, Oral Contraceptives Implanted Contraceptives, Injected Contraceptives, Intrauterine, others), Hormones, End-Users, Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2018 to 2025
Published On: March 2019
 
Report ID:375980
 
Category: Pharmaceutical
 
Pages: N/A




The global hormonal contraceptive market is expected to reach from USD 19.31 Billion in 2017 to USD 31.07 Billion by 2025 at a CAGR of 5.80% from 2018 to 2025. Increasing awareness about reproductive and sexual health worldwide and an increase in women population around the world are driving the growth of the market.

Market Overview:

Hormonal contraceptives are used as a birth control method. These pills act on the endocrine system. These are used to prevent ovulation and in turn pregnancy. However, they do not protect against HIV or other sexually transmitted infections. Two types of hormonal contraceptives are available in the market progestin-only contraceptive and combination hormonal contraceptive. Increasing focus towards family planning and the need for preventing teenage pregnancies are fuelling the market.

Report Description:

  • The base year for the study has been considered 2017, the historic year 2015 and 2016 and, the forecast period considered is from 2018 to 2025. The global hormonal contraceptive market is analyzed by value (USD Billion).
  • The study delivers a comprehensive analysis of the global hormonal contraceptive market by the method, hormones, end user and regions.
  • The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2018 to 2025.
  • Porter’s Five Forces model is used to recognize the competitive scenario in the global hormonal contraceptive market. This report incorporates the industry analysis which is focused on providing an extensive view of the global hormonal contraceptive market.
  • The study also includes attractiveness analysis method, hormones, end user and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
  • The report provides company profile of the key players operating in the global hormonal contraceptive market and a comparative analysis based on their business overviews, product offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
  • The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

Market Dynamics:

Drivers:

  • Increasing awareness regarding contraception methods in developing countries
  • Rising adoption of hormonal contraception for birth control
  • Growing female population worldwide
  • Urbanization and increased consciousness about contraception

Restraints:

  • Side effects associated with the use of hormonal contraceptives

Opportunities:

  • High demand for low-cost contraceptive practices in home care settings

Challenges:

  • Lack of awareness in emerging economies

Global Hormonal Contraceptive Market Key Findings:

All the segments have been analyzed on global, regional and country basis. The study includes an analysis of more than 30 countries for each segment.

Segmentation Analysis:

The global hormonal contraceptive market is segmented by the method, hormones, and end user.

  • The method segment is classified into combined oral, oral contraceptive, implanted, injected, intrauterine, transdermal patch, and vaginal ring contraceptives. The oral contraceptive segment accounted for the largest market share and was valued around USD 6.948 billion in 2017. Easy mode of administration, a wide range of availability and high awareness about pills are driving the growth of the segment.
  • Hormones segment is divided into androgens, estrogens, progestogens, gonadotropins, antiandrogens, and others. Increase in prevalence of PCOS, fewer side effects and effective results than progestin contraceptives makes other hormones preferred choice.
  • End-user segment is classified into hospitals, homecare, gynecology centers, clinics, and ambulatory surgical centers.

 

Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. North America region captured the largest share of the global hormonal contraceptive market and was valued around USD 8.87 billion in 2017 whereas Asia Pacific is expected to witness the highest CAGR in the forecast period.

  • North America region is expected to dominate the market owing to high income, the strong presence of major market players, higher awareness about sexual health and a large number of unintended pregnancies.
  • Asia Pacific is projected to be fastest growing region in the forecast period due to Large fertile population, the introduction of new female contraception devices and rise in investment by are the major factors supplementing the growth of the region.

Global Hormonal Contraceptive Market Competitive Analysis:

Major players operating in the global hormonal contraceptive market are Teva Pharmaceutical, Amgen, Sun Pharmaceutical, Bayer Healthcare, Piramal Healthcare, Cipla Limited, Pfizer, Inc., Glenmark Pharmaceuticals, Novartis AG, Lupin Pharmaceuticals, Reckitt Benckiser Plc, HLL Lifecare Limited, Boehringer Ingelheim GmbH, Watson Pharmaceuticals, Inc., V-Care Pharma Pvt. Ltd., Vardhman Life Care and others. Extensive product portfolio and expansion strategies by major players are contributing to the growth of the sector. For instance, in March 2017, TEVA launched generics of Minastrin 24 Fe-ethinyl estradiol & norethindrone acetate tablets and ferrous fumarate tablets. These are used as an oral contraceptive in the U.S.

This study forecasts revenue growth at global, regional, and country levels from 2015 to 2025. Fior Market Research has segmented the global hormonal contraceptive market by below-mentioned segments:

Global Hormonal Contraceptive Market, By Method:

  • Combined Oral Contraceptives
  • Oral Contraceptives
  • Implanted Contraceptives
  • Injected Contraceptives
  • Intrauterine
  • Trasdermal Patch
  • Vaginal Ring

Global Hormonal Contraceptive Market, By Hormones:

  • Androgens
  • Estrogens
  • Progestogens
  • Gonadotropins
  • Antiandrogens
  • Others

Global Hormonal Contraceptive Market, By End-Users:

  • Hospitals
  • Homecare
  • Gynecology Centers
  • Clinics
  • Ambulatory Surgical Centers

Global Hormonal Contraceptive Market, By Regions:

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Sweden
    • Netherlands
    • U.K.
    • Italy
    • Spain
    • Turkey
    • Switzerland
    • Belgium
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • The Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of The Middle East and Africa

*All our reports are customizable as per customer requirements

1. Introduction
   1.1. Objectives of the Study
   1.2. Market Definition
   1.3. Research Scope
   1.4. Currency

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
   4.1. Porter’s Five Forces Analysis
   4.2. Value Chain Analysis
   4.3. Top Investment Pockets
        4.3.1. Market attractiveness analysis by method
        4.3.2. Market attractiveness analysis by hormones
        4.3.3. Market attractiveness analysis by end user
        4.3.4. Market attractiveness analysis by region
   4.4. Industry Trends

5. Market Dynamics
   5.1. Market Evaluation
   5.2. Drivers
        5.2.1. Increasing Awareness Regarding Contraception Methods in Developing Countries
        5.2.2. Rising Adoption of Hormonal Contraception for Birth Control
        5.2.3. Growing Female Population Worldwide
        5.2.4. Urbanization and Increased Consciousness about Contraception
   5.3. Restraints
        5.3.1. Side Effects Associated with Use of Hormonal Contraceptives
   5.4. Opportunities
        5.4.1. High Demand For Low Cost Contraceptive Practices In Home Care Settings
   5.5. Challenges
        5.5.1. Lack of Awareness In Emerging Economies

6. Global Hormonal Contraceptive Market Analysis and Forecast, By Method
   6.1. Segment Overview
   6.2. Combined Oral Contraceptives
   6.3. Oral Contraceptives
   6.4. Implanted Contraceptives
   6.5. Injected Contraceptives
   6.6. Intrauterine
   6.7. Trasdermal Patch
   6.8. Vaginal Ring

7. Global Hormonal Contraceptive Market Analysis and Forecast, By Hormones
   7.1. Segment Overview
   7.2. Androgens
   7.3. Estrogens
   7.4. Progestogens
   7.5. Gonadotropins
   7.6. Antiandrogens
   7.7. Others

8. Global Hormonal Contraceptive Market Analysis and Forecast, By End User
   8.1. Segment Overview
   8.2. Hospitals
   8.3. Homecare
   8.4. Gynecology Centers
   8.5. Clinics
   8.6. Ambulatory Surgical Centers

9. Global Hormonal Contraceptive Market Analysis and Forecast, By Regional Analysis
   9.1. Segment Overview
   9.2. North America
        9.2.1. U.S.
        9.2.2. Canada
        9.2.3. Mexico
   9.3. Europe
        9.3.1. Germany
        9.3.2. France
        9.3.3. Sweden
        9.3.4. Netherlands
        9.3.5. U.K.
        9.3.6. Italy
        9.3.7. Spain
        9.3.8. Turkey
        9.3.9. Switzerland
        9.3.10. Belgium
        9.3.11. Rest of Europe
   9.4. Asia-Pacific
        9.4.1. Japan
        9.4.2. China
        9.4.3. India
        9.4.4. South Korea
        9.4.5. Australia
        9.4.6. Singapore
        9.4.7. Malaysia
        9.4.8. Thailand
        9.4.9. Indonesia
        9.4.10. Philippines
        9.4.11. Rest of Asia-Pacific
   9.5. South America
        9.5.1. Brazil
        9.5.2. Argentina
        9.5.3. Colombia
        9.5.4. Rest of South America
   9.6. Middle East and Africa
        9.6.1. Saudi Arabia
        9.6.2. UAE
        9.6.3. Egypt
        9.6.4. Nigeria
        9.6.5. South Africa
        9.6.6. Rest of  Middle East and Africa

10. Global Hormonal Contraceptive Market-Competitive Landscape
   10.1. Overview
   10.2. Market Share of Key Players in the Hormonal Contraceptive Market
        10.2.1. Global Company Market Share
        10.2.2. North America Company Market Share
        10.2.3. Europe Company Market Share
        10.2.4. APAC Company Market Share
   10.3. Competitive Situations and Trends
        10.3.1. Product Launches and Developments
        10.3.2. Partnerships, Collaborations, and Agreements
        10.3.3. Mergers & Acquisitions
        10.3.4. Expansions

11. Company Profiles
   11.1. Teva Pharmaceutical
        11.1.1. Business Overview
        11.1.2. Company Snapshot
        11.1.3. Company Market Share Analysis
        11.1.4. Company Product Portfolio
        11.1.5. Recent Developments
        11.1.6. SWOT Analysis
   11.2. Amgen
        11.2.1. Business Overview
        11.2.2. Company Snapshot
        11.2.3. Company Market Share Analysis
        11.2.4. Company Product Portfolio
        11.2.5. Recent Developments
        11.2.6. SWOT Analysis
   11.3. Sun Pharmaceutical
        11.3.1. Business Overview
        11.3.2. Company Snapshot
        11.3.3. Company Market Share Analysis
        11.3.4. Company Product Portfolio
        11.3.5. Recent Developments
        11.3.6. SWOT Analysis
   11.4. Bayer Healthcare
        11.4.1. Business Overview
        11.4.2. Company Snapshot
        11.4.3. Company Market Share Analysis
        11.4.4. Company Product Portfolio
        11.4.5. Recent Developments
        11.4.6. SWOT Analysis
   11.5. Piramal Healthcare
        11.5.1. Business Overview
        11.5.2. Company Snapshot
        11.5.3. Company Market Share Analysis
        11.5.4. Company Product Portfolio
        11.5.5. Recent Developments
        11.5.6. SWOT Analysis
   11.6. Cipla Limited
        11.6.1. Business Overview
        11.6.2. Company Snapshot
        11.6.3. Company Market Share Analysis
        11.6.4. Company Product Portfolio
        11.6.5. Recent Developments
        11.6.6. SWOT Analysis
   11.7. Pfizer, Inc.
        11.7.1. Business Overview
        11.7.2. Company Snapshot
        11.7.3. Company Market Share Analysis
        11.7.4. Company Product Portfolio
        11.7.5. Recent Developments
        11.7.6. SWOT Analysis
   11.8. Glenmark Pharmaceuticals
        11.8.1. Business Overview
        11.8.2. Company Snapshot
        11.8.3. Company Market Share Analysis
        11.8.4. Company Product Portfolio
        11.8.5. Recent Developments
        11.8.6. SWOT Analysis
   11.9. Novartis AG
        11.9.1. Business Overview
        11.9.2. Company Snapshot
        11.9.3. Company Market Share Analysis
        11.9.4. Company Product Portfolio
        11.9.5. Recent Developments
        11.9.6. SWOT Analysis
   11.10. Lupin Pharmaceuticals
        11.10.1. Business Overview
        11.10.2. Company Snapshot
        11.10.3. Company Market Share Analysis
        11.10.4. Company Product Portfolio
        11.10.5. Recent Developments
        11.10.6. SWOT Analysis
   11.11. Reckitt Benckiser Plc
        11.11.1. Business Overview
        11.11.2. Company Snapshot
        11.11.3. Company Market Share Analysis
        11.11.4. Company Product Portfolio
        11.11.5. Recent Developments
        11.11.6. SWOT Analysis
   11.12. HLL Lifecare Limited
        11.12.1. Business Overview
        11.12.2. Company Snapshot
        11.12.3. Company Market Share Analysis
        11.12.4. Company Product Portfolio
        11.12.5. Recent Developments
        11.12.6. SWOT Analysis
   11.13. Boehringer Ingelheim GmbH
        11.13.1. Business Overview
        11.13.2. Company Snapshot
        11.13.3. Company Market Share Analysis
        11.13.4. Company Product Portfolio
        11.13.5. Recent Developments
        11.13.6. SWOT Analysis
   11.14. Watson Pharmaceuticals, Inc
        11.14.1. Business Overview
        11.14.2. Company Snapshot
        11.14.3. Company Market Share Analysis
        11.14.4. Company Product Portfolio
        11.14.5. Recent Developments
        11.14.6. SWOT Analysis
   11.15. V-Care Pharma Pvt. Ltd.
        11.15.1. Business Overview
        11.15.2. Company Snapshot
        11.15.3. Company Market Share Analysis
        11.15.4. Company Product Portfolio
        11.15.5. Recent Developments
        11.15.6. SWOT Analysis


List of Table
1. Global Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
2. Global Combined Oral Contraceptives Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion) 
3. Global Oral Contraceptives Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
4. Global Implanted Contraceptives Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion) 
5. Global Injected Contraceptives Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion) 
6. Global Intrauterine Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion) 
7. Global Trasdermal Patch Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion) 
8. Global Vaginal Ring Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion) 
9. Global Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
10. Global Androgens Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
11. Global Estrogens Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
12. Global Progestogens Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
13. Global Gonadotropins Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
14. Global Neurosurgeries Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
15. Global Antiandrogens Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
16. Global Gynecological Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
17. Global Hormonal Contraceptive Market, By End-Users, 2015–2025 (USD Billion)
18. Global Hospitals Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
19. Global Homecare Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
20. Global Gynecology Centers Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
21. Global Clinics Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
22. Global Ambulatory Surgical Centers Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
23. Global Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion) 
24. North America Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
25. North America Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
26. North America Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
27. U.S. Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
28. U.S. Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
29. U.S. Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
30. Canada Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
31. Canada Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
32. Canada Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
33. Mexico Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
34. Mexico Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
35. Mexico Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
36. Europe Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
37. Europe Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
38. Europe Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
39. Germany Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
40. Germany Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
41. Germany Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
42. France Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
43. France Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
44. France Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
45. Sweden Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
46. Sweden Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
47. Sweden Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
48. Netherlands Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
49. Netherlands Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
50. Netherlands Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
51. U.K. Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
52. U.K. Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
53. U.K. Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
54. Italy Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
55. Italy Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
56. Italy Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
57. Spain Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
58. Spain Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
59. Spain Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
60. Turkey Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
61. Turkey Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
62. Turkey Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
63. Switzerland Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
64. Switzerland Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
65. Switzerland Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
66. Belgium Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
67. Belgium Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
68. Belgium Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion)
69. Asia Pacific Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
70. Asia Pacific Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
71. Asia Pacific Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
72. Japan Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
73. Japan Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
74. Japan Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
75. China Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
76. China Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
77. China Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
78. India Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
79. India Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
80. India Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
81. South Korea Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
82. South Korea Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
83. South Korea Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
84. Australia Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
85. Australia Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
86. Australia Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
87. Singapore Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
88. Singapore Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
89. Singapore Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
90. Malaysia Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
91. Malaysia Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
92. Malaysia Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
93. Thailand Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
94. Thailand Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
95. Thailand Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
96. Indonesia Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
97. Indonesia Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
98. Indonesia Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
99. Philippines Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
100. Philippines Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
101. Philippines Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
102. South America Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
103. South America Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
104. South America Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
105. Brazil Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
106. Brazil Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
107. Brazil Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
108. Argentina Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
109. Argentina Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
110. Argentina Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
111. Colombia Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
112. Colombia Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
113. Colombia Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
114. Middle East and Africa Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
115. Middle East and Africa Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
116. Middle East and Africa Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
117. Saudi Arabia Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
118. Saudi Arabia Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
119. Saudi Arabia Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
120. UAE Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
121. UAE Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
122. Egypt Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
123. Egypt Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
124. Egypt Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
125. Nigeria Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
126. Nigeria Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
127. Nigeria Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
128. South Africa Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
129. South Africa Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
130. South Africa Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 

List of Figures 
1. Global Hormonal Contraceptive Market Segmentation
2. Hormonal Contraceptive Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis 
7. Value Chain Analysis 
8. Global Hormonal Contraceptive Market attractiveness analysis by Method
9. Global Hormonal Contraceptive Market attractiveness analysis by Hormones
10. Global Hormonal Contraceptive Market attractiveness analysis by End User
11. Global Hormonal Contraceptive Market attractiveness analysis by Region
12. Global Hormonal Contraceptive Market: Dynamics
13. Global Hormonal Contraceptive Market Share by Method (2017 & 2025)
14. Global Hormonal Contraceptive Market Share by Hormones (2017 & 2025)
15. Global Hormonal Contraceptive Market Share by End User (2017 & 2025)
16. Global Hormonal Contraceptive Market Share by Regions (2017 & 2025)
17. Global Hormonal Contraceptive Market Share by Company (2018)



Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
   Our Clients
  • \


Copyright © 2019 Fior Market Research LLP, All Rights Reserved.